A common vape flavoring may disrupt early embryo development

A recent study led by UC Riverside researchers suggests that the flavoring chemical vanillin, often used in e-cigarettes, may disrupt the normal development of human embryos. The findings, published in Human Reproduction, shed light on the potential link between vaping and difficulties in pregnancy, including miscarriages. The research, conducted using human embryonic stem cells, found that exposure to micromolar concentrations of vanillin led to the loss of stem cells' ability to differentiate into various cell types, and caused them to develop primarily into endoderm cells.

This could have serious implications for the normal development of embryos. The study's lead author, Prue Talbot, emphasized that the results cannot definitively prove the same effects in pregnant women or developing embryos. However, the researchers stress the importance of caution, given that nanomolar concentrations of vanillin may reach the embryo in pregnant women who vape.

They recommend that pregnant women avoid vaping and that e-cigarette manufacturers disclose ingredients on product packaging. The study also calls for regulatory policies to consider the potential harm to unborn children from exposure to e-cigarette flavorants.